Enliven Therapeutics, Inc. (ELVN) total assets

Total assets · fiscal 2025
$476.17M

Enliven Therapeutics, Inc. (ELVN) had total assets of $476.17M at the end of fiscal 2025 (December 31, 2025). That is 46.2% higher than the $325.76M of fiscal 2024. Figures as of 18 Nov 2026, 10:35 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total assets, fiscal 2025
$476.17M
Change on fiscal 2024
+46.2%
Growth, 5 years
+39.3% a year
Highest on record
$476.17Mfiscal 2025
Lowest on record
$33.30Mfiscal 2019
Fiscal years on record
72019–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Enliven Therapeutics, Inc. total assets, in more detail

Over the five fiscal years to 2025 total assets grew at a compound 39.3% a year. Across the 7 fiscal years on record (2019–2025), the highest was $476.17M in fiscal 2025 and the lowest $33.30M in fiscal 2019.

History · 7 fiscal years

Total assets by fiscal year

Enliven Therapeutics, Inc. total assets, year by year

Enliven Therapeutics, Inc. (ELVN) total assets by fiscal year
Fiscal yearTotal assetsChangeYear ended
2025$476.17M 46.2% up
2024$325.76M 19.8% up
2023$271.87M 226.4% up
2022$83.30M 11.1% down
2021$93.65M 3.1% up
2020$90.84M 172.8% up
2019$33.30M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total assets is everything on the balance sheet at the fiscal year-end — cash, receivables, inventory, property, goodwill and the rest.

How to read it

It measures the resources the business has put to work; assets that grow faster than profit mean each new unit of investment is earning less.

More on ELVN

Enliven Therapeutics, Inc., figure by figure

Enliven Therapeutics, Inc. (ELVN) overview: price, valuation and scorecard

Enliven Therapeutics, Inc. total assets: questions and answers

How large are Enliven Therapeutics, Inc.'s total assets?

Enliven Therapeutics, Inc. (ELVN) had total assets of $476.17M at the end of fiscal 2025 (December 31, 2025). That is 46.2% higher than the $325.76M of fiscal 2024.

What is the growth rate of Enliven Therapeutics, Inc.'s total assets?

Over the five fiscal years to 2025 total assets grew at a compound 39.3% a year.

What are the highest and lowest total assets figures on record for Enliven Therapeutics, Inc.?

Across the 7 fiscal years on record (2019–2025), the highest was $476.17M in fiscal 2025 and the lowest $33.30M in fiscal 2019.

How is Enliven Therapeutics, Inc.'s total assets calculated?

Total assets is everything on the balance sheet at the fiscal year-end — cash, receivables, inventory, property, goodwill and the rest. For Enliven Therapeutics, Inc. it is on record here for 7 fiscal years, 2019 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Enliven Therapeutics, Inc. (ELVN) total assets”, data as of 18 November 2026. https://funkfolio.com/stock/ELVN/total-assets

Underlying data: the company's filings with the SEC and Yahoo Finance.